Found: 21
Select item for more details and to access through your institution.
Biological consequences of MLC calibration errors in IMRT delivery and QA.
- Published in:
- Medical Physics, 2012, v. 39, n. 4, p. 1917, doi. 10.1118/1.3692177
- By:
- Publication type:
- Article
The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models.
- Published in:
- Supportive Care in Cancer, 2018, v. 26, n. 7, p. 2217, doi. 10.1007/s00520-018-4064-x
- By:
- Publication type:
- Article
The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mathematical prediction with pretreatment growth rate of metastatic cancer on outcomes: implications for the characterization of oligometastatic disease.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1061881
- By:
- Publication type:
- Article
Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
- Published in:
- Acta Oncologica, 2010, v. 49, n. 7, p. 1040, doi. 10.3109/0284186X.2010.509736
- By:
- Publication type:
- Article
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Re‐irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectives.
- Published in:
- Journal of Applied Clinical Medical Physics, 2018, v. 19, n. 6, p. 341, doi. 10.1002/acm2.12481
- By:
- Publication type:
- Article
Consistency in electronic portal imaging registration in prostate cancer radiation treatment verification.
- Published in:
- Radiation Oncology, 2006, v. 1, p. 37, doi. 10.1186/1748-717X-1-37
- By:
- Publication type:
- Article
Markerless dynamic tumor tracking (MDTT) radiotherapy using diaphragm as a surrogate for liver targets.
- Published in:
- Journal of Applied Clinical Medical Physics, 2024, v. 25, n. 2, p. 1, doi. 10.1002/acm2.14161
- By:
- Publication type:
- Article
In‐vivo quality assurance of dynamic tumor tracking (DTT) for liver SABR using EPID images.
- Published in:
- Journal of Applied Clinical Medical Physics, 2023, v. 24, n. 7, p. 1, doi. 10.1002/acm2.13969
- By:
- Publication type:
- Article
Four‐dimensional dose calculations for dynamic tumour tracking with a gimbal‐mounted linear accelerator.
- Published in:
- Journal of Applied Clinical Medical Physics, 2021, v. 22, n. 6, p. 16, doi. 10.1002/acm2.13265
- By:
- Publication type:
- Article
Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion-positive lung cancer patient.
- Published in:
- Journal of Medical Radiation Sciences, 2016, v. 63, n. 1, p. 67, doi. 10.1002/jmrs.144
- By:
- Publication type:
- Article
Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 120, doi. 10.1016/j.clcc.2022.10.006
- By:
- Publication type:
- Article
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 8, p. 1537, doi. 10.1002/cncr.27911
- By:
- Publication type:
- Article
Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01219
- By:
- Publication type:
- Article
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression.
- Published in:
- Current Oncology, 2023, v. 30, n. 8, p. 7499, doi. 10.3390/curroncol30080543
- By:
- Publication type:
- Article
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 305, doi. 10.1186/1471-2407-12-305
- By:
- Publication type:
- Article